HeraMED Limited Cash Flow Conversion Efficiency

Latest as of December 2021: 8.075x

HeraMED Limited cash flow conversion efficiency. Based on the latest financial reports, HeraMED Limited (1I4) has a cash flow conversion efficiency ratio of 8.075x as of December 2021. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-855.85K ≈ $-1.00 Million USD) by net assets (€-105.98K ≈ $-123.91K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of HeraMED Limited (2018–2021)

Cash flow conversion efficiency of HeraMED Limited from 2018 to 2021. This chart illustrates how HeraMED Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View HeraMED Limited (1I4) stock price for real-time trading data and today's change.

HeraMED Limited Cash Flow Conversion Ratio Explained

HeraMED Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

HeraMED Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of HeraMED Limited ranked by their cash flow conversion efficiency. Also see 1I4 company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
ENVIONEER Co.Ltd KQ:317870	0.015x
Duksung KO:004830	0.014x
Jembo Cable Company Tbk JK:JECC	-0.109x
SPARK VC S.A. ZY 10 F:8N2	-0.015x
Central Petroleum Ltd AU:CTP	0.120x
Eskay Mining Corp V:ESK	-0.087x
Enertork Ltd KQ:019990	-0.033x
Farmer Bros. Co NASDAQ:FARM	-0.125x

Annual Cash Flow Conversion Efficiency for HeraMED Limited (2018–2021)

The table below shows the annual cash flow conversion efficiency of HeraMED Limited from 2018 to 2021. Review 1I4 free cash flow debt coverage to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2021-12-31	€-105.98K ≈ $-123.91K	€-3.23 Million ≈ $-3.78 Million	30.493x	+2946.50%
2020-12-31	€2.59 Million ≈ $3.03 Million	€-2.78 Million ≈ $-3.25 Million	-1.071x	-38.01%
2019-12-31	€3.41 Million ≈ $3.98 Million	€-2.65 Million ≈ $-3.09 Million	-0.776x	-170.25%
2018-12-31	€6.15 Million ≈ $7.19 Million	€-1.77 Million ≈ $-2.06 Million	-0.287x	--

About HeraMED Limited

F:1I4 Germany Medical Devices

Market Cap

$27.68 Million

€23.68 Million EUR

Market Cap Rank

#23891 Global

#2077 in Germany

Share Price

€0.02

Change (1 day)

-19.61%

52-Week Range

€0.02 - €0.03

All Time High

€0.03